Strategic Wealth Partners, Ltd.
Position in TCRX — TScan Therapeutics, Inc.
CIK 1720777
INDEPENDENCE, OH
Position in TCRX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$314
+$3 QoQ
Shares Held
311
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TCRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Strategic Wealth Partners, Ltd. holds $2,573,928 across 29 Biotechnology names. TCRX ranks #23 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,058 | $2,258,599 | |
| 2 | CMPX |
Compass Therapeutics, Inc.
|
16,825 | $89,004 | |
| 3 | ARGX |
Argenx SE
|
72 | $52,578 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52 | $40,177 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
607 | $28,874 | |
| 6 | TECH |
BIO-TECHNE Corp
|
351 | $18,343 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
654 | $18,115 | |
| 8 | RNAC |
Cartesian Therapeutics, Inc.
|
2,029 | $12,478 |
All Filings in TCRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $314 | 311 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $311 | 311 | Shares | Sole | 2026-05-12 | |
| 2025-09-30 | $566 | 311 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $450 | 311 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||